Results 21 to 30 of about 1,937,987 (265)
Journal of Medical Case Reports, 2022 Introduction Recombinant adenoviral vector vaccines against severe acute respiratory syndrome coronavirus 2 have been observed to be associated with vaccine-induced immune thrombotic thrombocytopenia.
Sandra Emily Stoll +9 more
doaj +1 more source
Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments
HemaSphere, 2021 Immune thrombocytopenia (ITP) is a rare autoimmune disease due to both a peripheral destruction of platelets and an inappropriate bone marrow production.
S. Audia +5 more
semanticscholar +1 more source
How I approach new onset thrombocytopenia
Platelets, 2020 Thrombocytopenia is a common reason for referral to hematologists in community and hospital practice. A broad differential diagnosis, combined with the potentially life-threatening nature of some presentations necessitates a rapid evaluation of the ...
Fiona Swain, Robert Bird
doaj +1 more source
Expert Review of Hematology, 2021 Introduction Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet count (
J. Bussel +4 more
semanticscholar +1 more source
Primary immune thrombocytopenia in children
Pediatria Polska, 2021 Primary immune thrombocytopenia (ITP) is usually a benign and self-limiting disease in children. Due to the complex pathogenesis involving different immunological processes, its course may be unpredictable.
Agnieszka Książek, Tomasz Szczepański
doaj +1 more source
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
Journal of Blood Medicine, 2021 The rollout of the SARS-CoV-2 vaccine is underway, and millions have already been vaccinated. At least 25 reports of “immune thrombocytopenia” (ITP) or “thrombocytopenia” following the Moderna or Pfizer vaccine have been added to the Vaccine Adverse ...
J. Helms +6 more
semanticscholar +1 more source
Exacerbation of immune thrombocytopenia following COVID‐19 vaccination
British Journal of Haematology, 2021 There is concern that COVID‐19 vaccination may adversely affect immune thrombocytopenia (ITP) patients. Fifty‐two consecutive chronic ITP patients were prospectively followed after COVID‐19 vaccination.
D. Kuter
semanticscholar +1 more source
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy [PDF]
, 2016 Preclinical models suggest that histone deacetylase (HDAC) and mammalian target of rapamycin (mTOR) inhibitors have synergistic anticancer activity. We designed a phase I study to determine the safety, maximum tolerated dose (MTD), recommended phase II ...
et al,, Park, Haeseong
core +5 more sources
Vaccines, 2021 We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine administration.
Po-Wei Liao +2 more
doaj +1 more source
Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
Journal of Clinical Medicine, 2021 Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is associated with frequent bruising and bleeding. Current evidence suggests that low
Anurag Singh, G. Uzun, T. Bakchoul
semanticscholar +1 more source